(GHM) Graham - Overview
Stock: Ejectors, Condensers, Turbines, Pumps, Heat Exchangers
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 57.6% |
| Relative Tail Risk | -8.87% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.65 |
| Alpha | 58.22 |
| Character TTM | |
|---|---|
| Beta | 1.504 |
| Beta Downside | 1.101 |
| Drawdowns 3y | |
|---|---|
| Max DD | 46.46% |
| CAGR/Max DD | 1.93 |
Description: GHM Graham December 27, 2025
Graham Corporation (NYSE:GHM) is a U.S.-based designer and manufacturer of fluid-power, heat-transfer, and vacuum equipment serving chemical, petrochemical, defense, space, petroleum-refining, cryogenic, and broader energy markets.
Its product suite spans power-plant ejectors and surface condensers; torpedo-grade propulsion and power hardware such as turbines, alternators, regulators, pumps, and blowers; and thermal-management solutions-including pumps, blowers, and drive electronics-for defense, energy, and aerospace customers. The firm also supplies rocket-propulsion turbopumps, cryogenic and nuclear propellant pumps, cooling systems, and life-support fans for the space sector, plus a global spare-parts service network.
Operating across the United States, Canada, Asia, the Middle East, and South America, Graham reported FY 2023 revenue of roughly $1.2 billion with an 8 % operating margin and a backlog of about $500 million, indicating solid order flow despite cyclical pressures. Key economic drivers include: (1) sustained growth in global petrochemical capacity additions, which boosts demand for high-efficiency heat-transfer and vacuum equipment; (2) rising U.S. defense spending that underpins contracts for torpedo and thermal-management systems; and (3) accelerating commercial launch activity that fuels demand for rocket-propulsion turbopumps and life-support hardware.
For a deeper quantitative dive into Graham’s valuation dynamics, you might explore the company’s profile on ValueRay to see how its fundamentals stack up against sector peers.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 14.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA -9.53 > 1.0 |
| NWC/Revenue: 3.85% < 20% (prev 2.40%; Δ 1.45% < -1%) |
| CFO/TA 0.04 > 3% & CFO 12.5m > Net Income 14.9m |
| Net Debt (-16.2m) to EBITDA (19.2m): -0.84 < 3 |
| Current Ratio: 1.06 > 1.5 & < 3 |
| Outstanding Shares: last quarter (11.2m) vs 12m ago 0.90% < -2% |
| Gross Margin: 24.63% > 18% (prev 0.25%; Δ 2438 % > 0.5%) |
| Asset Turnover: 85.27% > 50% (prev 75.54%; Δ 9.73% > 0%) |
| Interest Coverage Ratio: 104.3 > 6 (EBITDA TTM 19.2m / Interest Expense TTM 141.0k) |
Altman Z'' 2.37
| A: 0.03 (Total Current Assets 163.8m - Total Current Liabilities 154.7m) / Total Assets 292.9m |
| B: 0.36 (Retained Earnings 104.8m / Total Assets 292.9m) |
| C: 0.05 (EBIT TTM 14.7m / Avg Total Assets 278.6m) |
| D: 0.62 (Book Value of Equity 99.4m / Total Liabilities 161.6m) |
| Altman-Z'' Score: 2.37 = BBB |
Beneish M -3.47
| DSRI: 0.37 (Receivables 31.7m/72.8m, Revenue 237.6m/199.6m) |
| GMI: 1.01 (GM 24.63% / 24.82%) |
| AQI: 0.88 (AQ_t 0.23 / AQ_t-1 0.26) |
| SGI: 1.19 (Revenue 237.6m / 199.6m) |
| TATA: 0.01 (NI 14.9m - CFO 12.5m) / TA 292.9m) |
| Beneish M-Score: -3.47 (Cap -4..+1) = AA |
What is the price of GHM shares?
Over the past week, the price has changed by +16.08%, over one month by +19.89%, over three months by +37.19% and over the past year by +117.88%.
Is GHM a buy, sell or hold?
- StrongBuy: 3
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the GHM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 75.5 | -11.2% |
| Analysts Target Price | 75.5 | -11.2% |
| ValueRay Target Price | 143.5 | 68.7% |
GHM Fundamental Data Overview February 07, 2026
P/E Forward = 109.8901
P/S = 3.5558
P/B = 6.3031
P/EG = 0.7701
Revenue TTM = 237.6m USD
EBIT TTM = 14.7m USD
EBITDA TTM = 19.2m USD
Long Term Debt = 44.0k USD (from longTermDebtTotal, last fiscal year)
Short Term Debt = 1.48m USD (from shortTermDebt, last quarter)
Debt = 6.05m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -16.2m USD (from netDebt column, last quarter)
Enterprise Value = 794.2m USD (810.4m + Debt 6.05m - CCE 22.3m)
Interest Coverage Ratio = 104.3 (Ebit TTM 14.7m / Interest Expense TTM 141.0k)
EV/FCF = -129.9x (Enterprise Value 794.2m / FCF TTM -6.11m)
FCF Yield = -0.77% (FCF TTM -6.11m / Enterprise Value 794.2m)
FCF Margin = -2.57% (FCF TTM -6.11m / Revenue TTM 237.6m)
Net Margin = 6.28% (Net Income TTM 14.9m / Revenue TTM 237.6m)
Gross Margin = 24.63% ((Revenue TTM 237.6m - Cost of Revenue TTM 179.1m) / Revenue TTM)
Gross Margin QoQ = 23.75% (prev 21.67%)
Tobins Q-Ratio = 2.71 (Enterprise Value 794.2m / Total Assets 292.9m)
Interest Expense / Debt = 2.33% (Interest Expense 141.0k / Debt 6.05m)
Taxrate = 11.18% (358.0k / 3.20m)
NOPAT = 13.1m (EBIT 14.7m * (1 - 11.18%))
Current Ratio = 1.06 (Total Current Assets 163.8m / Total Current Liabilities 154.7m)
Debt / Equity = 0.05 (Debt 6.05m / totalStockholderEquity, last quarter 131.3m)
Debt / EBITDA = -0.84 (Net Debt -16.2m / EBITDA 19.2m)
Debt / FCF = 2.65 (negative FCF - burning cash) (Net Debt -16.2m / FCF TTM -6.11m)
Total Stockholder Equity = 125.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 5.36% (Net Income 14.9m / Total Assets 292.9m)
RoE = 11.90% (Net Income TTM 14.9m / Total Stockholder Equity 125.5m)
RoCE = 11.72% (EBIT 14.7m / Capital Employed (Equity 125.5m + L.T.Debt 44.0k))
RoIC = 10.58% (NOPAT 13.1m / Invested Capital 123.5m)
WACC = 11.39% (E(810.4m)/V(816.4m) * Re(11.46%) + D(6.05m)/V(816.4m) * Rd(2.33%) * (1-Tc(0.11)))
Discount Rate = 11.46% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 1.08%
Fair Price DCF = unknown (Cash Flow -6.11m)
EPS Correlation: 60.28 | EPS CAGR: 86.18% | SUE: -2.63 | # QB: 0
Revenue Correlation: 92.60 | Revenue CAGR: 9.94% | SUE: 1.19 | # QB: 2
EPS next Year (2027-03-31): EPS=1.88 | Chg30d=+0.062 | Revisions Net=+2 | Growth EPS=+45.7% | Growth Revenue=+12.8%